journal
MENU ▼
Read by QxMD icon Read
search

Dermatologic Therapy

journal
https://www.readbyqxmd.com/read/29124847/potassium-iodide-a-forgotten-remedy-for-cutaneous-cryptococcosis
#1
LETTER
Rajsmita Bhattacharjee, Keshavamurthy Vinay, Debajyoti Chatterjee, Tarun Narang
No abstract text is available yet for this article.
November 10, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29124831/a-prospective-observational-study-to-compare-efficacy-of-topical-triamcinolone-acetonide-0-1-oral-paste-oral-methotrexate-and-a-combination-of-topical-triamcinolone-acetonide-0-1-and-oral-methotrexate-in-moderate-to-severe-oral-lichen-planus
#2
P Chauhan, D De, S Handa, T Narang, U N Saikia
Topical corticosteroids are considered to be the most effective treatment for oral lichen planus (OLP). Methotrexate has been found to be effective in extensive cutaneous lichen planus. The objectives of the study were to evaluate the clinical efficacy and safety of topical triamcinolone 0.1% oral paste, oral methotrexate and a combination of these in symptomatic moderate-to- severe OLP. Forty-five patients were recruited and were allocated to three treatment arms with 15 patients in each treatment arm. They were treated for a period of 16 weeks or until complete clinical remission, whichever was earlier...
November 10, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29124830/janus-kinase-inhibitors-for-the-use-of-alopecia-areata-a-promising-therapeutic-of-the-future
#3
LETTER
Katelyn Mariko Updyke
No abstract text is available yet for this article.
November 10, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29094450/management-of-pediatric-psoriasis-with-acitretin-a-review
#4
REVIEW
Smriti Subedi, Qian Yu, Zeyu Chen, Yuling Shi
Psoriasis is a chronic inflammatory disease of the skin which can occur at any age-group. Psoriasis in childhood is not uncommon and has genetic susceptibility but usually, an environmental trigger such as infection is thought to initiate the disease process. Pediatric psoriasis has profound effects on both physical and psychosocial health of the patient. Treatment of mild psoriasis can be done with topical therapies but those which do not respond to topical therapies can be treated with phototherapy and systemic therapies...
November 1, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29082602/comparison-of-clinical-efficacy-and-safety-of-thermotherapy-versus-cryotherapy-in-treatment-of-skin-warts-a-randomized-controlled-trial
#5
Leila Izadi Firouzabadi, Ali Khamesipour, Narges Ghandi, Hamed Hosseini, Amir Teymourpour, Alireza Firooz
The effect of thermotherapy in the treatment of skin warts in comparison to cryotherapy, as the standard conventional method, has remained uncertain. This study aimed to assess the clinical efficacy and safety of thermotherapy and cryotherapy in removing skin warts. This randomized controlled trial was conducted on 52 patients aged 18 years and over with ≤ 10 skin warts. The participants were randomly assigned into two groups to receive cryotherapy (every 2 to 3 weeks up to six sessions if required) or thermotherapy (one session)...
October 30, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29082587/effectiveness-and-safety-of-polidocanol-for-the-treatment-of-hemangiomas-and-vascular-malformations-a-meta-analysis
#6
REVIEW
Zhi Gao, Yi Zhang, Wei Li, Chen Shi
A meta-analysis was conducted to investigate the efficacy and safety of polidocanol versus other conventional therapies in treating hemangiomas (HMs) and vascular malformations (VMs). Literature search was conducted in the Cochrane, Embase, PubMed, Web of Science, CNKI, CBM, VIP, and WanFang databases until March 5, 2017. A meta-analysis was conducted using Revman 5.3 software. A total of 19 randomized controlled trials (RCTs) involving 1,514 participants met the inclusion criteria. Regarding the effectiveness, statistically significant differences were observed between polidocanol and all the independent treatments (p = ...
October 30, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29082596/unconventional-use-of-fractional-ablative-co2-laser-in-facial-cutaneous-sarco%C3%A3-dosis
#7
LETTER
Anissa Zaouak, Wafa Koubaa, Houda Hammami, Samy Fenniche
No abstract text is available yet for this article.
October 29, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29047198/evaluation-of-narrow-band-ultraviolet-b-phototherapy-in-the-treatment-of-chronic-actinic-dermatitis-in-chinese-patients
#8
Li Ma, Qiaoan Zhang, Yue Hu, Xiaoqun Luo
Few studies have been conducted in chronic actinic dermatitis (CAD) treated with narrowband ultraviolet B (NB UVB) phototherapy, especially in Asian patients. We aim to evaluate the efficacy and safety of NB UVB phototherapy in Chinese patients with CAD. 19 CAD patients of Fitzpatrick skin phototype IV received NB UVB phototherapy in spring and treatments were given 3 times weekly with incremental dose and maintenance therapy was given twice weekly for 3-4 weeks. The mean initial, endpoint, and cumulative dose of NB UVB was 0...
October 19, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29034554/pd1-inhibitors-and-hair-repigmentation-a-desirable-new-side-effect
#9
LETTER
Lilia M Correa-Selm, James M Grichnik
No abstract text is available yet for this article.
October 15, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29034547/refractory-pityriasis-rubra-pilaris-treated-with-etanercept-adalimumab-or-ustekinumab-a-retrospective-investigation
#10
Nolan J Maloney, Lisa D Hisaw, Scott Worswick
Pityriasis rubra pilaris (PRP) is a rare, difficult to treat papulosquamous disorder that responds variably to retinoids and immunosuppression. Successful use of biologics for treating PRP has been described in the literature by case reports and a limited number of case series. To provide additional data, we retrospectively analyzed cases of PRP treated with biologics at our institution. We identified seven patients with a clear diagnosis of PRP treated with adalimumab, etanercept, and/or ustekinumab at our institution from January 1, 2014 to April 1, 2017...
October 15, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29028144/treatment-of-pediatric-anogenital-condyloma-acuminata-with-sinecatechins-ointment
#11
LETTER
Elena Godoy-Gijon, María Carmen Fraile-Alonso, Carmen Alonso-Vicente, Silvia Rojo-Rello
No abstract text is available yet for this article.
October 13, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/29028142/local-hyperthermia-therapy-for-refractory-cutaneous-mycobacterium-marinum-infection
#12
LETTER
Chaw-Ning Lee, Julia Yu-Yun Lee
No abstract text is available yet for this article.
October 13, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28994169/methotrexate-induced-pneumonia-a-dermatologist-wake-up-call
#13
LETTER
Ayman Abdelmaksoud
No abstract text is available yet for this article.
October 10, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28994166/newer-treatments-of-psoriasis-regarding-il-23-inhibitors-phosphodiesterase-4-inhibitors-and-janus-kinase-inhibitors
#14
REVIEW
Dominika Wcisło-Dziadecka, Martyna Zbiciak-Nylec, Ligia Brzezińska-Wcisło, Katarzyna Bebenek, Agata Kaźmierczak
The rapid progress of genetic engineering furthermore opens up new prospects in the therapy of this difficult-to-treat disease. IL-23 inhibitors, phosphodiesterase 4 (PDE4) inhibitors, and Janus kinase (JAK) inhibitors are currently encouraging further research. Two drugs which are IL-23 inhibitors are now in phase III of clinical trials. The aim of the action of both drugs is selective IL-23 inhibition by targeting the p19 subunit. Guselkumab is a fully human monoclonal antibody. Tildrakizumab is a humanized monoclonal antibody, which also belongs to IgG class and is targeted to subunit p19 of interleukin 23 (IL-23)...
October 10, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28976720/infliximab-induced-acne-and-acute-localized-exanthematous-pustulosis-case-report
#15
LETTER
Simona Senilă, Andrada Seicean, Oana Fechete, Alecsandra Grad, Loredana Ungureanu
No abstract text is available yet for this article.
October 4, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28976682/erythrodermic-psoriasis-peculiarly-sparing-anti-tnf-injection-sites-in-a-patient-with-secondary-loss-of-efficacy
#16
LETTER
Dipali Malvankar Kapoor, Ki-Wei Tan
No abstract text is available yet for this article.
October 4, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28976625/amelanotic-melanoma-arising-within-a-lesion-of-disseminated-superficial-actinic-porokeratosis-an-unusual-presentation-leading-to-a-novel-therapeutic-approach
#17
Ali Al-Haseni, Pooja Chitgopeker, Jonathan D Ho, Lynne J Goldberg, Debjani Sahni
Disseminated superficial actinic porokeratosis (DSAP) is the most common variant of porokeratosis with a potential for malignant transformation. Its association with malignant melanoma, however, is exceedingly rare. Treatment of DSAP is often ineffective. We report a unique case of amelanotic melanoma arising within a lesion of DSAP. The melanoma was managed surgically, and her DSAP were treated successfully with a novel approach utilizing 5-fluorouracil chemowraps.
October 4, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28976624/vismodegib-persistence-and-discontinuation-patterns-in-greek-patients-from-a-real-world-setting
#18
Efthymia Soura, Michaela Plaka, Vasiliki Chasapi, Christina Antoniou, Alexander Stratigos
Hedghehog pathway inhibitors have been successfully used for patients with locally advanced basal cell carcinomas. However, these treatments have been associated with various adverse events that may limit patient compliance. In this study, an association of patient and disease characteristics with drug compliance in a real clinical setting was made. 18 patients were included in the study. The average patient age was 78.39 years. The time that patients remained to treatment was, on average, 8.73 months. 72.2% of patients experienced at least one adverse event...
October 4, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28940579/treatment-of-psoriasis-with-topical-agents-recommendations-from-a-tuscany-consensus
#19
Andrea Chiricozzi, Nicola Pimpinelli, Federica Ricceri, Giovanni Bagnoni, Laura Bartoli, Mauro Bellini, Luca Brandini, Marzia Caproni, Antonio Castelli, Michele Fimiani, Franco Marsili, Carlo Mazzatenta, Maria Chiara Niccoli, Salvatore Panduri, Michele Pellegrino, Riccardo Sirna, Walter Volpi, Marco Romanelli, Francesca Prignano
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythematous and scaly plaques. Treatment approach is mainly driven by disease severity, though several factors should be considered in order to identify the optimal therapeutic choice. Mild psoriasis may be treated with a wide array of topical agents including corticosteroids, vitamin D analogs, keratolytics, and calcipotriol/betamethasone propionate compound. Because guidelines may not provide practical indications regarding the therapeutic approach, the use of topical agents in psoriasis is more individually tailored...
September 20, 2017: Dermatologic Therapy
https://www.readbyqxmd.com/read/28906051/effectiveness-and-safety-of-secukinumab-in-69-patients-with-moderate-to-severe-plaque-psoriasis-a-retrospective-multicenter-study
#20
J F Schwensen, A Clemmensen, C Sand, R Gniadecki, L Skov, C Zachariae, L Iversen, M Rasmussen, S F Thomsen
Secukinumab (anti-IL17A) is effective as treatment for moderate to severe plaque psoriasis, but real-life data on effectiveness and safety lack. We aimed to present real-life data of all Danish patients treated with secukinumab (n = 69). At baseline, before initiation of treatment with secukinumab 300 mg (47.8%) or off-label treatment with secukinumab 150 mg (52.2%), the median PASI score was 7.1. A total of 66.7% (34/51) and 52.9% (27/51) of patients still on secukinumab at week 12 achieved a PASI (Psoriasis Area and Severity Index)-50 and PASI-75 of 66...
September 14, 2017: Dermatologic Therapy
journal
journal
32674
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"